×
News Home

Is BioCardia Inc (BCDA) Stock About to Get Hot Wednesday?

Wednesday, December 16, 2020 11:25 AM | InvestorsObserver Analysts
Is BioCardia Inc (BCDA) Stock About to Get Hot Wednesday?

BioCardia Inc (BCDA) stock is up 118.87% over the past week and gets a Bullish rating from InvestorsObserver's Sentiment Indicator.

Sentiment Score - ,bullish
BioCardia Inc has a Bullish sentiment reading. Find out what this means for you and get the rest of the rankings on BCDA!

What is Stock Sentiment?

Sentiment uses short term technical analysis to gauge whether a stock is desired by investors. As a technical indicator, it focuses on recent trends as opposed to the long term health of the underlying company. Updates for the company such as a earnings release can move the stock away from current trends.

Sentiment is how investors, or the market, feels about a stock. There are lots of ways to measure sentiment. At the core, sentiment is pretty easy to understand. If a stock is going up, investors must be bullish, while if it is going down, sentiment is bearish.

InvestorsObserver’s Sentiment Indicator looks at price trends over the past week and also considers changes in volume. Increasing volume can mean a trend is getting stronger, while decreasing volume can mean a trend is nearing a conclusion.

For stocks that have options, our system also considers the balance between calls, which are often bets that the price will go up, and puts, which are frequently bets that the price will fall.

What's Happening With BCDA Stock Today?

BioCardia Inc (BCDA) stock is down -13.51% while the S&P 500 is up 0.13% as of 11:24 AM on Wednesday, Dec 16. BCDA has fallen -$0.90 from the previous closing price of $6.70 on volume of 5,472,116 shares. Over the past year the S&P 500 is up 15.92% while BCDA is up 44.64%. BCDA lost -$1.96 per share in the over the last 12 months.

To screen for more stocks like BioCardia Inc click here.

More About BioCardia Inc

BioCardia Inc is a clinical stage regenerative medicine company. It is developing therapeutics for cardiovascular diseases with large unmet medical needs. The company is developing comprehensive biotherapeutic candidates for cardiac regenerative medicine namely CardiAMP and CardiALLO, with a focus on heart failure resulting from a heart attack.

Click Here to get the full Stock Score Report on BioCardia Inc (BCDA) Stock.

You May Also Like

Get the InvestorsObserver App

InvestorsObserver App
iOS App Android App